Genital hypersensitivity and premature ejaculation caused by withdrawal of citalopram resolves with each reinstatement

This is a place to post research you have done on the topic along with your conclusions.
User avatar
anacleta
Posts: 695
Joined: Fri Jan 23, 2015 5:47 am
Contact:

Genital hypersensitivity and premature ejaculation caused by withdrawal of citalopram resolves with each reinstatement

Unread post by anacleta »

a case from 2003 before the PSSD name was even created.

Premature ejaculation associated with citalopram withdrawal

David E Adson 1, Michael Kotlyar

PMID: 14632589

DOI: 10.1345/aph.1D214

Abstract

Objective: To report a case of premature ejaculation occurring subsequent to citalopram discontinuation.

Case summary: A 43-year-old white man being treated for depression with citalopram wished to discontinue treatment. Four or 5 days after stopping citalopram he reported that, during sexual intercourse, his genitals seemed to be extremely sensitive and orgasm was achieved within approximately 1 minute. These symptoms continued over the next 3-4 weeks and remitted after citalopram was restarted. Several subsequent attempts to discontinue citalopram resulted in a return of these symptoms despite using a slow tapering regimen. An objective causality assessment revealed a probable relationship between drug withdrawal and the observed symptoms.

Discussion: The ability of selective serotonin-reuptake inhibitors (SSRIs) to delay ejaculation has been well documented; however, discontinuation of these agents generally results in a return to baseline function. Although discontinuation of SSRI therapy has been associated with a number of withdrawal symptoms, this is the first report (MEDLINE, September 2003), to our knowledge, of the emergence of sexual adverse effects in someone with no previous history of these symptoms.

Conclusions: Premature ejaculation is a possible withdrawal effect after SSRI discontinuation. Since patients are usually reluctant to spontaneously report sexual adverse effects, it is important to specifically inquire about them both when starting and stopping treatment with an SSRI.

https://pubmed.ncbi.nlm.nih.gov/14632589/
Post Reply

Who is online

Users browsing this forum: Ahrefs [Bot] and 4 guests